Enzo Biochem to Present at Cantor Fitzgerald Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Enzo Biochem (ENZ) Announces Issuance of Construction Order in Ten Ongoing Patent Suits
July 8, 2015 9:17 AM EDTEnzo Biochem (NYSE: ENZ) announced that the United States District Court for the District of Delaware has issued a claim construction order governing ten ongoing patent litigations brought by Enzo against eleven companies regarding Enzos U.S. Patent Nos. 6,992,180; 7,064,197; and 8,097,405.
In its claim construction ruling, the Court adopted Enzos proposed constructions for the majority of the disputed claim terms. The Court... More
